Immunic (IMUX) Stock Chart & Stock Price History → Strange new buyer driving up gold (From Stansberry Research) (Ad) Free IMUX Stock Alerts $1.21 -0.06 (-4.72%) (As of 02:20 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Immunic Stock Price Performance5 Day Performance-11.81%1 Month Performance-3.79%3 Month Performance+10.92%6 Month Performance+11.40%Year-To-Date Performance-15.33%1 Year Performance-22.56% Receive IMUX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Immunic and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry ResearchStrange new buyer driving up goldOne Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."But there's a much better move you can make to get in front of these big moves today. IMUX Stock Chart for Friday, April, 19, 2024 IMUX Chart by TradingView Immunic Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/18/2024$1.21$1.27+4.96%$1.32$1.20280,208 shs$114.21 million04/17/2024$1.28$1.21-5.47%$1.29$1.21188,325 shs$108.82 million04/16/2024$1.31$1.28-2.29%$1.33$1.24270,960 shs$115.11 million04/15/2024$1.44$1.31-9.03%$1.43$1.27378,080 shs$117.81 million04/12/2024$1.40$1.44+2.86%$1.46$1.40417,016 shs$129.50 million04/11/2024$1.39$1.40+0.72%$1.42$1.33216,806 shs$125.90 million Get the Latest News and Ratings for IMUX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immunic and its competitors with MarketBeat's FREE daily newsletter. 04/10/2024$1.29$1.39+7.75%$1.41$1.27318,154 shs$125.00 million04/09/2024$1.29$1.29$1.34$1.26219,615 shs$116.01 million04/08/2024$1.28$1.29+0.78%$1.31$1.25167,338 shs$116.01 million04/05/2024$1.23$1.28+4.07%$1.33$1.22486,271 shs$115.11 million04/04/2024$1.22$1.23+0.82%$1.26$1.19296,062 shs$110.61 million04/03/2024$1.22$1.22$1.26$1.17293,250 shs$109.72 million04/02/2024$1.36$1.22-10.29%$1.35$1.21346,518 shs$109.72 million04/01/2024$1.32$1.36+3.03%$1.39$1.29236,767 shs$122.31 million03/29/2024$1.32$1.32$1.34$1.30215,951 shs$118.71 million03/28/2024$1.30$1.32+1.54%$1.33$1.30215,110 shs$118.71 million03/27/2024$1.28$1.30+1.56%$1.32$1.26170,626 shs$116.91 million03/26/2024$1.30$1.28-1.54%$1.32$1.28268,001 shs$115.11 million03/25/2024$1.32$1.30-1.52%$1.34$1.30137,050 shs$116.91 million03/22/2024$1.34$1.32-1.49%$1.37$1.32197,934 shs$118.71 million03/21/2024$1.38$1.34-2.90%$1.42$1.34219,219 shs$120.51 million03/20/2024$1.32$1.38+4.55%$1.40$1.31240,692 shs$124.10 million03/19/2024$1.31$1.32+0.76%$1.35$1.29411,550 shs$118.71 million03/18/2024$1.31$1.31$1.36$1.26461,847 shs$117.81 million03/15/2024$1.30$1.31+0.77%$1.38$1.302.73 million shs$117.81 million03/14/2024$1.33$1.30-2.26%$1.35$1.28328,039 shs$116.91 million03/13/2024$1.36$1.33-2.21%$1.45$1.33436,804 shs$119.61 million03/12/2024$1.43$1.36-4.90%$1.46$1.35465,799 shs$122.30 million03/11/2024$1.53$1.43-6.54%$1.56$1.43417,193 shs$128.60 million03/08/2024$1.46$1.53+4.79%$1.63$1.491.06 million shs$137.59 million03/07/2024$1.47$1.46-0.68%$1.51$1.43478,843 shs$131.30 million03/06/2024$1.50$1.47-2.00%$1.54$1.43542,025 shs$132.20 million03/05/2024$1.53$1.50-1.96%$1.57$1.49631,365 shs$134.90 million03/04/2024$1.45$1.53+5.52%$1.55$1.39903,804 shs$137.59 million03/01/2024$1.47$1.45-1.02%$1.55$1.42883,316 shs$65.51 million02/29/2024$1.40$1.47+4.64%$1.47$1.36653,047 shs$66.19 million02/28/2024$1.39$1.40+0.72%$1.47$1.38846,118 shs$63.25 million02/27/2024$1.28$1.39+8.59%$1.43$1.321.11 million shs$62.80 million02/26/2024$1.22$1.28+4.92%$1.34$1.22721,074 shs$57.83 million02/23/2024$1.22$1.22$1.26$1.20648,120 shs$55.12 millionStrange new buyer driving up gold (Ad)One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."But there's a much better move you can make to get in front of these big moves today.02/22/2024$1.28$1.22-4.69%$1.31$1.171.07 million shs$55.12 million02/21/2024$1.36$1.28-5.54%$1.36$1.26991,917 shs$57.83 million02/20/2024$1.26$1.36+7.54%$1.37$1.26791,682 shs$61.22 million02/19/2024$1.26$1.26$1.33$1.241.09 million shs$56.93 million02/16/2024$1.34$1.26-5.97%$1.33$1.241.09 million shs$56.93 million02/15/2024$1.31$1.34+2.29%$1.40$1.31877,495 shs$60.50 million02/14/2024$1.16$1.31+12.93%$1.37$1.171.71 million shs$59.15 million02/13/2024$1.23$1.16-5.69%$1.23$1.13930,565 shs$52.37 million02/12/2024$1.22$1.23+0.82%$1.25$1.20424,818 shs$55.53 million02/09/2024$1.22$1.22$1.28$1.21577,248 shs$55.08 million02/08/2024$1.21$1.22+0.83%$1.25$1.20336,105 shs$55.08 million02/07/2024$1.24$1.21-2.42%$1.27$1.21322,444 shs$54.63 million02/06/2024$1.18$1.24+5.08%$1.27$1.18669,699 shs$55.99 million02/05/2024$1.22$1.18-3.28%$1.22$1.18578,113 shs$53.28 million02/02/2024$1.23$1.22-0.81%$1.25$1.20297,646 shs$55.08 million02/01/2024$1.19$1.23+3.36%$1.24$1.20292,289 shs$55.53 million01/31/2024$1.21$1.19-1.65%$1.26$1.18658,555 shs$53.73 million01/30/2024$1.16$1.21+4.31%$1.29$1.15919,934 shs$54.63 million01/29/2024$1.15$1.16+1.31%$1.19$1.133.58 million shs$52.37 million01/26/2024$1.14$1.15+0.44%$1.16$1.13276,750 shs$51.70 million01/25/2024$1.15$1.14-0.87%$1.16$1.12390,605 shs$51.47 million01/24/2024$1.14$1.15+0.88%$1.17$1.14958,039 shs$51.92 million01/23/2024$1.16$1.14-1.30%$1.16$1.13413,838 shs$51.47 million01/22/2024$1.15$1.16+0.87%$1.20$1.111.18 million shs$52.15 million01/19/2024$1.19$1.15-3.78%$1.20$1.141.33 million shs$51.70 million01/18/2024$1.21$1.19-1.65%$1.21$1.13560,826 shs$53.73 million Related Companies: Adagene Stock Price Chart Societal CDMO Stock Price Chart Coya Therapeutics Stock Price Chart Citius Pharmaceuticals Stock Price Chart Annovis Bio Stock Price Chart InterCure Stock Price Chart Cyteir Therapeutics Stock Price Chart OptiNose Stock Price Chart Cellectar Biosciences Stock Price Chart Repare Therapeutics Stock Price Chart Receive IMUX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Immunic and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IMUX) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceSHOCKING Crypto Leak…Crypto 101 MediaHow Biden has already won 2024Porter & CompanyMy biggest AI fearParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.